Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

SCOTUS Grapples With Marketing of Vascepa Generic With 'Skinny Label'

SCOTUS Grapples With Marketing of Vascepa Generic With 'Skinny Label'
ShareXFacebook

(MedPage Today) -- How far can a generic drugmaker with a so-called skinny label go in publicizing a generic version of a brand-name drug? The Supreme Court heard arguments on this question Wednesday, but didn't give a clear indication of which...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement